November 24th 2024
Patients experienced similar safety and efficacy if they received first-line or later-line treatment for unresectable hepatocellular carcinoma (u-HCC).
Telerehabilitation Reduces Pain, Improves Function for People With Musculoskeletal Needs
July 10th 2022Participants in a digital acute musculoskeletal (MSK) program experienced better pain and function outcomes vs nonparticipants, demonstrating benefits for acute and subacute MSK conditions.
Read More
Contributor: Technology, Supplemental Services in MA Can Help Improve Participant Health
July 10th 2022Social determinants of health present many health-related challenges for Medicare Advantage (MA) plan members, something these plans are looking to overcome by diversifying their service offerings.
Read More
Certain Factors May Reduce ESS-Induced Smell Improvement in CRSwNP
July 9th 2022Endoscopic sinus surgery was associated with improvement in self-reported olfactory function among patients with chronic rhinosinusitis with nasal polyps (CRSwNP), in which a longer CRSwNP disease course and higher blood eosinophilia were cited as risk factors linked with poor sense of smell recovery.
Read More
Potential Link Found Between Heart Failure Prognosis, Changes in RVFAC
July 8th 2022Few data exist on how right ventricular fractional area change (RVFAC) may contribute to outcomes among patients hospitalized for heart failure, so that potential relationship was investigated in this new study from Japan.
Read More
Inpatient Opioid Receipt and Care Experiences for Vaginal Delivery
The objective of this study was to examine the relationship between inpatient opioid receipt and care experiences of women hospitalized for vaginal delivery.
Read More
Patients With Cancer Face Major Financial Roadblocks, Not All Concerning Out-of-Pocket Costs
July 7th 2022Abstracts presented at this year's American Society of Clinical Oncology Annual meeting detailed the financial hardships many patients with cancer face, including those related to high-deductible health plans and clinical trial participation.
Read More
Method of Tissue Acquisition May Determine Success of Gene Sequencing in Lung Cancer
July 7th 2022Successful comprehensive genomic profiling of tissue samples among patients with lung cancer was more likely to occur when samples were extracted via resections vs fluid cytology, biopsy, or fine-needle aspirations.
Read More
Targeting β Cells May Hold Promise for Preventing and Treating T1D
July 7th 2022Although the autoimmune response that reduces β cell numbers has often been the focus of research in type 1 diabetes (T1D), findings from a new study suggest proinflammatory signaling in islet β cells may play a significant role in disease progression.
Read More
Drug Survival of Psoriasis Biologics Associated With Efficacy, Safety Profile
July 6th 2022Drug survival rates of biologics in patients with psoriasis were shown to be associated with their effectiveness and safety profiles, in which incidence of psoriatic arthritis, nail involvement, and other factors were indicated as effect modifiers.
Read More
Contributor: COVID-19 Ranked Among the Top 5 Telehealth Diagnoses Nationally in April 2022
July 6th 2022COVID-19 was ranked in the top 5 diagnoses through telehealth in the Midwest, Northeast, and West regions as well as nationally in the month of April, coinciding with an increase in COVID-19 cases.
Read More
How Machine Learning, Digital Therapeutics Improve Personalized Care
July 5th 2022Panelists at the National Alliance of Healthcare Purchaser Coalitions 2022 Leadership Summit discussed the latest innovations in digital therapeutics and how they benefit patients on an individual and broad scale.
Read More
Evaluating Value-Based Contracting in Behavioral Health: A Q&A With Vanessa Bobb, MD, PhD, FAPA
July 5th 2022At AHIP 2022, Vanessa Bobb, MD, PhD, FAPA, vice president of Behavioral Health & Medical Integration at CDPHP, moderated a session on real-world study findings showcasing cost and quality benefits of value-based contracting in behavioral health. Bobb discusses findings of the study and how value-based programs can be better leveraged in mental health and substance abuse care.
Read More
Dupilumab Demonstrates Safety, Efficacy Across Several Type 2 Inflammatory Diseases
July 2nd 2022Research presented at the European Academy of Allergy and Clinical Immunology Annual Congress show the safety and efficacy of dupilumab across several progressive diseases with underlying type 2 inflammation, including eosinophilic esophagitis (EoE), severe asthma, and severe chronic rhinosinusitis with nasal polyps.
Read More
Initiation of Nusinersen for SMA Soon After Birth May Allow for Normal Outcomes
July 2nd 2022Publishing their findings on the earliest treated infants to date, the researchers detailed the outcomes of 2 patients treated with nusinersen in their first week of life after receiving a spinal muscular atrophy (SMA) prenatal diagnosis.
Read More
Exercise Capacity in HFpEF Not Impaired by Reduced Diastolic Filling Time
July 2nd 2022Using chronotropic response as a reference, study authors from Japan investigated the potential influence of exercise-induced heart rate on cardiac output reserve and exercise capacity among a cohort of patients with heart failure with preserved ejection fraction (HFpEF).
Read More
Dr Elaine Siegfried on Preventive Strategies to Reduce Comorbidity Risk in Atopic Dermatitis
July 2nd 2022Elaine Siegfried, MD, professor of pediatrics and dermatology, Saint Louis University Health Sciences Center, addresses the comorbidity profile associated with atopic dermatitis and the utility of disease-modifying drugs to reduce risk of comorbid conditions.
Watch
Achieving Equity Warrants Change in Public Health Policy and Investment, Panel Says
July 1st 2022Panelists of a keynote session at AHIP 2022 discuss how lessons learned from investment and infrastructure in public health during the COVID-19 pandemic can be leveraged to promote equitable care for all Americans and prepare for the next public health emergency.
Read More